Dr. Snydman brings 35 years of experience in observational and interventional studies in translational research, including transplant recipients, hemodialysis patients, and other hospitalized patients. He has also successfully carried out a number of clinical trials in a variety of patient populations, one of which was developed fully by Dr. Snydman and led to the licensure of a biologic product through the FDA. He has mentored over 30 post-doctoral fellows, many of whom have gone on to write successful K23s and other awards, most of whom have developed independent research careers. Dr. Snydman is currently working on a number of translational projects including the role of iron regulation and hepcidin in infections post liver transplant, the role of microbiota in immune regulation of compromised hosts, and projects looking at C. difficile in compromised hosts and hospitalized patients.
David R. Snydman, MD, FACP, FIDSA
Professor of Medicine
Tufts Medical Center
Tufts Medical Center